Nvrts uses SMS 2 get meds 2 pts in Africa
This article was originally published in Scrip
Novartis is making (air)waves in Africa with a simple tool – SMS, or text messaging – to manage medicine stocks. The company is piloting its SMS for Life programme in Kenya after success in Tanzania while governments elsewhere want to get on board, too.
You may also be interested in...
The R&D-based lobby group, Medicines Australia, has published a report calling for stakeholders across the Australian healthcare ecosystem to discuss how to “pragmatically address the evidence needs of the future.”
NICE will review new data in deciding whether to ok the use of Spinraza in non-ambulant SMA type III patients.
WTO member states including the EU, the US and the UK argue that waiving certain IP rights is unnecessary for enhancing responses to the Covid-19 pandemic.